Increased antimicrobial resistance in a novel CMY-54 AmpC-type enzyme with a GluLeu217-218 insertion in the Ω-loop

Pérez-Llarena, Francisco José; Vázquez-Ucha, Juan Carlos; Kerff, Frédéric; Zamorano, Laura; Beceiro, Alejandro; Miro, Elisenda; Póvoa Cabral, Maria; Fleites, Ana; Lantero, Marta; Martínez-Martínez, Luis; Martínez-Martínez, Antonio; Galleni, Moreno; Navarro, Ferrán; Bou, Germán

doi:10.1089/mdr.2017.0017

Request a copy

Article (Scientific journals)

Increased antimicrobial resistance in a novel CMY-54 AmpC-type enzyme with a GluLeu217-218 insertion in the Ω-loop

Pérez-Llarena, Francisco José; Vázquez-Ucha, Juan Carlos; Kerff, Frédéric et al.

2018 • In Microbial Drug Resistance: Mechanism, Epidemiology, and Disease

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/211976

DOI
10.1089/mdr.2017.0017

PubMed
28665771

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

manuscript CMY-54 10-1 MDR-FK.docx

Author preprint (123.28 kB)

Request a copy

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

Biochemistry, biophysics & molecular biology

Author, co-author :

Pérez-Llarena, Francisco José

Vázquez-Ucha, Juan Carlos

Kerff, Frédéric ; Université de Liège > Département des sciences de la vie > Centre d'ingénierie des protéines

Zamorano, Laura

Beceiro, Alejandro

Miro, Elisenda

Póvoa Cabral, Maria

Fleites, Ana

Lantero, Marta

Martínez-Martínez, Luis

More authors (4 more)

Language :

English

Title :

Increased antimicrobial resistance in a novel CMY-54 AmpC-type enzyme with a GluLeu217-218 insertion in the Ω-loop

Publication date :

2018

Journal title :

Microbial Drug Resistance: Mechanism, Epidemiology, and Disease

ISSN :

1076-6294

eISSN :

1931-8448

Publisher :

Mary Ann Liebert, Inc., Larchmont, United States - New York

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 20 June 2017

Statistics

Number of views

140 (13 by ULiège)

Number of downloads

1 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

Bibliography

Beceiro, A., and G. Bou. 2004. Class C b-lactamases: an increasing problemworldwide.Rev.Med.Microb. 15:141-152.
Jacoby, G.A. 2009. AmpC b-lactamases. Clin. Microbiol. Rev. 22:161-182.
Pérez-Llarena, F.J., and G. Bou. 2009. Beta lactamase inhibitors: the story so far. Curr. Med. Chem. 16:3740-3745.
Drawz, S.M., and R.A. Bonomo. 2010. Three decades of betalactamase inhibitors. Clin. Microbiol. Rev. 23:160-201.
Papp-Wallace, K.M., M.L.Winkler, J.A. Gatta, M.A. Taracila, S. Chilakala, Y. Xu, J.K. Johnson, and R.A. Bonomo. 2014. Reclaiming the efficacy of b-lactam-b-lactamase inhibitor combinations: avibactam restores the susceptibility of CMY-2-producing Escherichia coli to ceftazidime. Antimicrob. Agents Chemother. 58:4290-4297.
Sidjabat H.E., K.Y. Seah, L. Coleman, A. Sartor, P. Derrington, C. Heney, J. Faoagali, G.R. Nimmo, and D.L. Paterson. 2014. Expansive spread of IncI1 plasmids carrying blaCMY-2 amongst Escherichia coli. Int. J. Antimicrob. Agents 44:203-208.
Doi, Y., D.L. Paterson, J.M. Adams-Haduch, H.E. Sidjabat, A. O'Keefe, A. Endimiani, and R.A. Bonomo. 2009. Reduced susceptibility to cefepime among Escherichia coli clinical isolates producing novel variants of CMY-2 betalactamase. Antimicrob. Agents Chemother. 53:3159-3161.
Dahyot, S., and H. Mammeri. 2012. Hydrolysis spectrum extension of CMY-2-like b-lactamases resulting from structural alteration in the Y-X-N loop. Antimicrob. Agents Chemother. 56:1151-1156.
Clinical and Laboratory Standards Institute. 2012. Methods for Dilution on Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition. M07-A9, vol. 32, no. 2. Clinical and Laboratory Standards Institute, Wayne, PA.
García, A., F. Navarro, E. Miró, L. Villa, B. Mirelis, P. Coll, and A. Carattoli. 2007. Acquisition and diffusion of blaCTX-M-9 gene by R478-IncHI2 derivative plasmids. FEMS Microbiol. Lett. 271:71-77.
Verdet, C., V. Gautier, E. Chachaty, E. Ronco, N. Hichi, D. Decre, and G. Arlet. 2009. Genetic context of plasmidcarried blaCMY-2-like genes in Enterobacteriaceae. Antimicrob. Agents Chemother. 53:4002-4006.
Beceiro, A., F.J. Pérez-Llarena, A. Pérez, M. Tomás Mdel, A. Fernández, S. Mallo, R. Villanueva, and G. Bou. 2007. Molecular characterization of the gene encoding a new AmpC b-lactamase in Acinetobacter baylyi. J. Antimicrob. Chemother. 59:996-1000.
Galleni, M., N. Franceschini, B. Quinting, L. Fattorini, G. Orefici, A. Oratore, J.M. Frère, and G. Amicosante. 1994. Use of the chromosomal class A b-lactamase of Mycobacterium fortuitum D316 to study potentially poor substrates and inhibitory beta-lactam compounds. Antimicrob. Agents Chemother. 38:1608-1614.
Bou, G., E. Santillana, A. Sheri, A. Beceiro, J.M. Sampson,M. Kalp, C.R. Bethel, A.M. Distler, S.M. Drawz, S.R. Pagadala, F. van den Akker, R.A. Bonomo, A. Romero, and J.D. Buynak. 2010. Design, synthesis, and crystal structures of 6-alkylidene-2′-substituted penicillanic acid sulfones as potent inhibitors of Acinetobacter baumannii OXA-24 carbapenemase. J. Am. Chem. Soc. 29:13320-13331.
Matagne, A., A.M. Misselyn-Bauduin, B. Joris, T. Erpicum, B. Granier, and J.M. Frère. 2014. The diversity of the catalytic properties of class A b-lactamases. Biochem. J. 1990;265: 131-146.
Krieger, E., and G. Vriend. YASARA View-molecular graphics for all devices-from smartphones to workstations. Bioinformatics 15:2981-2982.
Miró, E., J. Aguero, M.N. Larrosa, A. Fernandez, M.C. Conejo, G. Bou, J.J. Gonzalez-Gonzalez, N. Lara, L. Martinez-Martinez, A. Oliver, B. Aracil, J. Oteo, A. Pascual, J. Rodriguez-Baño, L. Zamorano, and F. Navarro. 2013. Prevalence and molecular epidemiology of acquired AmpC beta-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur. J. Clin. Microbiol. Infect. Dis. 32:253-259
Erratum Eur. J. Clin. Microbiol. Infect. Dis. 2013; 32:261-262.
Su, L.H., C. Chu, A. Cloeckaert, and C.H. Chiu. 2008. An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae. FEMS Immunol.Med.Microbiol. 52:155-168.
Endimiani, A., Y. Doi, C.R. Bethel, M. Taracila, J.M. Adams-Haduch, A. O'Keefe, A.M. Hujer, D.L. Paterson, M.J. Skalweit, M.G. Page, S.M. Drawz, and R.A. Bonomo. 2010. Enhancing resistance to cephalosporins in class C blactamases: impact of Gly214Glu in CMY-2. Biochemistry 49:1014-1023.
Papp-Wallace, K.M., S. Mallo, C.R. Bethel, M.A. Taracila, A.M. Hujer, A. Fernandez, J.A. Gatta, K.M. Smith, Y. Xu, M.G. Page, E. Desarbre, G. Bou, and R.A. Bonomo. 2014. A kinetic analysis of the inhibition of FOX-4 b-lactamase, a plasmid-mediated AmpC cephalosporinase, by monocyclic b-lactams and carbapenems. J. Antimicrob. Chemother. 69: 682-690.
Kotsakis, S.D., C.C. Papagiannitsis, E. Tzelepi, L.S. Tzouvelekis, and V. Miriagou. 2009. Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase. Antimicrob. Agents Chemother. 53: 3520-3523.
Nukaga, M., S. Haruta, K. Tanimoto, K. Kogure, K. Taniguchi, M. Tamaki, and T. Sawai. 1995. Molecular evolution of a class C b-lactamase extending its substrate specificity. J. Biol. Chem. 270:5729-5735.
Kim, J.Y., H.I. Jung, Y.J. An, J.H. Lee, S.J. Kim, S.H. Jeong, K.J. Lee, P.G. Suh, H.S. Lee, S.H. Lee, and S.S. Cha. 2006. Structural basis for the extended substrate spectrum of CMY-10, a plasmid-encoded class C betalactamase. Mol. Microbiol. 60:907-916.
Wang, X., G. Minasov, and B.K. Shoichet. 2002. Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. J. Mol. Biol. 320:85-95.
Chen, Y., J. Delmas, J. Sirot, B. Shoichet, and R. Bonnet. 2005 Atomic resolution structures of CTX-M b-lactamases: extended spectrum activities from increased mobility and decreased stability. J. Mol. Biol. 348:349-362.
Mehta, S.C., K. Rice, and T. Palzkill. 2015. Natural variants of the KPC-2 carbapenemase have evolved increased catalytic efficiency for ceftazidime hydrolysis at the cost of enzyme stability. PLoS Pathog. 11:e1004949.
Yi, H., J.M. Choi, J. Hwang, F. Prati, T.P. Cao, S.H. Lee, and H.S. Kim. 2016. High adaptability of the omega loop underlies the substrate-spectrum-extension evolution of a class A b-lactamase. Sci. Rep. 6:36527.
Lahiri, S.D., G.K. Walkup, J.D. Whiteaker, T. Palmer, K. McCormack, M.A. Tanudra, T.J. Nash, J. Thresher, M.R. Johnstone, L. Hajec, S. Livchak, R.E. McLaughlin, and R.A Alm. 2015. Selection and molecular characterization of ceftazidime/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC. J. Antimicrob. Chemother. 70:1650-1658.